指南与共识泌尿男性生殖肿瘤支持与姑息治疗

国际老年肿瘤学会关于老年患者前列腺癌管理的更新推荐

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients.
指南 / 共识 · Eur J Cancer · 2019-06-10

国际老年肿瘤学会(SIOG)2018年成立多学科工作组,检索2016年6月至2018年6月文献及EAU、ESMO、ASCO、ASCO GU会议摘要,更新老年前列腺癌管理推荐。2019共识认为75岁及以上患者应依据个体健康状态而非年龄管理,并将患者分为健康/体健、脆弱、衰弱三组分别给出治疗建议。

要点

  • 75岁及以上前列腺癌患者应依据个体健康状态而非年龄进行管理。
  • 患者按健康状态分为健康/体健、脆弱、衰弱三组。
  • 健康/体健者可选择与年轻患者相同的治疗方案。

核心结论

  • 2019年共识认为75岁及以上前列腺癌男性应依据个体健康状态而非年龄进行管理。

研究设计与样本

  • SIOG于2018年成立多学科工作组更新推荐,检索2016年6月至2018年6月相关文献及同期EAU、ESMO、ASCO、ASCO GU会议摘要,最终稿件反映专家共识。

主要发现

  • 基于现有快速健康筛查工具、老年评估和老年干预,工作组推荐将患者按健康状态分为三组。
  • 健康或体健患者应具有与年轻患者相同的治疗选择。
  • 脆弱患者适合接受老年干预,若干预成功可能使其适合接受标准治疗。
  • 衰弱且有严重功能障碍的患者应接受调整治疗或姑息治疗。
  • 2019年SIOG工作组推荐还讨论了老年前列腺癌患者日常实践中健康状态评估的前景和未满足需求。

关键数值与推荐

  • 75岁及以上前列腺癌男性应依据个体健康状态而非年龄管理。
  • 健康或体健患者应具有与年轻患者相同的治疗选择。
  • 脆弱患者适合接受老年干预,若干预成功可能使其适合接受标准治疗。
  • 衰弱且有严重功能障碍的患者应接受调整治疗或姑息治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The median age of prostate cancer diagnosis is 66 years, and the median age of men who die of the disease is eighty years. The public health impact of prostate cancer is already substantial and, given the rapidly ageing world population, can only increase. In this context, the International Society of Geriatric Oncology (SIOG) Task Forces have, since 2010, been developing guidelines for the management of senior adults with prostate cancer. MATERIAL AND METHODS: Since prostate cancer and geriatric oncology are both rapidly evolving fields, a new multidisciplinary Task Force was formed in 2018 to update SIOG recommendations, principally on health status screening tools and treatment. The task force reviewed pertinent articles published between June 2016 and June 2018 and abstracts from European Association of Urology (EAU), European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and American Society of Clinical Oncology Genito-urinary (ASCO GU) meetings over the same period, using search terms relevant to prostate cancer, the elderly, geriatric evaluation, local treatments and advanced disease. Each member of the group proposed modifications to the previous guidelines. These were collated and circulated. The final manuscript reflects the expert consensus. RESULTS: The 2019 consensus is that men aged 75 years and older with prostate cancer should be managed according to their individual health status, and not according to age. Based on available rapid health screening tools, geriatric evaluation and geriatric interventions, the Task Force recommends that patients are classified according to health status into three groups: (1) 'healthy' or 'fit' patients should have the same treatment options as younger patients; (2) 'vulnerable' patients are candidates for geriatric interventions which-if successful-may make it appropriate for them to receive standard treatment and (3) 'frail' patients with major impairments who should receive adapted or palliative treatment. The 2019 SIOG Task Force recommendations also discuss prospects and unmet needs for health status evaluation in everyday practice in older patients with prostate cancer.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Boyle HJ, Alibhai S, Decoster L, et al. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. Eur J Cancer. 2019. PMID: 31195356. doi:10.1016/j.ejca.2019.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。